1
|
Irani S: Distant metastasis from oral
cancer: A review and molecular biologic aspects. J Int Soc Prev
Community Dent. 6:265–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Simard EP, Torre LA and Jemal A:
International trends in head and neck cancer incidence rates:
Differences by country, sex and anatomic site. Oral Oncol.
50:387–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Russo D, Merolla F, Mascolo M, Ilardi G,
Romano S, Varricchio S, Napolitano V, Celetti A, Postiglione L, Di
Lorenzo PP, et al: FKBP51 immunohistochemical expression: A new
prognostic biomarker for OSCC? Int J Mol Sci. 18:4432017.
View Article : Google Scholar :
|
4
|
Silverman S Jr: Demographics and
occurrence of oral and pharyngeal cancers. The outcomes, the
trends, the challenge. J Am Dent Assoc. 132(Suppl): S7–S11. 2001.
View Article : Google Scholar
|
5
|
Kujan O, Glenny AM, Duxbury J, Thakker N
and Sloan P: Evaluation of screening strategies for improving oral
cancer mortality: A Cochrane systematic review. J Dent Educ.
69:255–265. 2005.PubMed/NCBI
|
6
|
Wakita D, Chamoto K, Ohkuri T, Narita Y,
Ashino S, Sumida K, Nishikawa H, Shiku H, Togashi Y, Kitamura H, et
al: IFN-gamma-dependent type 1 immunity is crucial for
immunosurveillance against squamous cell carcinoma in a novel mouse
carcinogenesis model. Carcinogenesis. 30:1408–1415. 2009.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Hayakawa Y, Sato-Matsushita M, Takeda K,
Iwakura Y, Tahara H and Irimura T: Early activation and
interferon-γ production of tumor-infiltrating mature CD27 high
natural killer cells. Cancer Sci. 102:1967–1971. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hong M, Jiang Z and Zhou YF: Effects of
thermotherapy on Th1/Th2 cells in esophageal cancer patients
treated with radiotherapy. Asian Pac J Cancer Prev. 15:2359–2362.
2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chen J, Hou J, Zhang J, An Y, Zhang X, Yue
L, Liu J and Li X: Atorvastatin synergizes with IFN-γ in treating
human non-small cell lung carcinomas via potent inhibition of RhoA
activity. Eur J Pharmacol. 682:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gattoni A, Parlato A, Vangieri B,
Bresciani M and Derna R: Interferon-gamma: Biologic functions and
HCV therapy (type I/II) (1 of 2 parts). Clin Ter. 157:377–386.
2006.PubMed/NCBI
|
11
|
Chung TW, Tan KT, Chan HL, Lai MD, Yen MC,
Li YR, Lin SH and Lin CC: Induction of indoleamine 2,3-dioxygenase
(IDO) enzymatic activity contributes to interferon-gamma induced
apoptosis and death receptor 5 expression in human non-small cell
lung cancer cells. Asian Pac J Cancer Prev. 15:7995–8001. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Hastie C: Interferon gamma, a possible
therapeutic approach for late-stage prostate cancer? Anticancer
Res. 28B:2843–2849. 2008.
|
13
|
El Jamal SM, Taylor EB, Abd Elmageed ZY,
Alamodi AA, Selimovic D, Alkhateeb A, Hannig M, Hassan SY,
Santourlidis S, Friedlander PL, et al: Interferon gamma-induced
apoptosis of head and neck squamous cell carcinoma is connected to
indoleamine-2,3-dioxygenase via mitochondrial and ER
stress-associated pathways. Cell Div. 11:112016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Pirot P, Eizirik DL and Cardozo AK:
Interferon-gamma potentiates endoplasmic reticulum stress-induced
death by reducing pancreatic beta cell defence mechanisms.
Diabetologia. 49:1229–1236. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Watanabe Y, Suzuki O, Haruyama T and
Akaike T: Interferon-gamma induces reactive oxygen species and
endoplasmic reticulum stress at the hepatic apoptosis. J Cell
Biochem. 89:244–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cardozo AK, Ortis F, Storling J, Feng YM,
Rasschaert J, Tonnesen M, Van Eylen F, Mandrup-Poulsen T, Herchuelz
A and Eizirik DL: Cytokines downregulate the sarcoendoplasmic
reticulum pump Ca2+ ATPase 2b and deplete endoplasmic
reticulum Ca2+, leading to induction of endoplasmic
reticulum stress in pancreatic beta-cells. Diabetes. 54:452–461.
2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Denmeade SR and Isaacs JT: The SERCA pump
as a therapeutic target: Making a 'smart bomb' for prostate cancer.
Cancer Biol Ther. 4:14–22. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Rao RV, Hermel E, Castro-Obregon S, del
Rio G, Ellerby LM, Ellerby HM and Bredesen DE: Coupling endoplasmic
reticulum stress to the cell death program. Mechanism of caspase
activation. J Biol Chem. 276:33869–33874. 2001. View Article : Google Scholar : PubMed/NCBI
|
19
|
Foskett JK, White C, Cheung KH and Mak DO:
Inositol trisphosphate receptor Ca2+ release channels.
Physiol Re. 87:593–658. 2007. View Article : Google Scholar
|
20
|
Papp S, Dziak E, Michalak M and Opas M: Is
all of the endoplasmic reticulum created equal? The effects of the
heterogeneous distribution of endoplasmic reticulum
Ca2+-handling proteins. J Cell Biol. 160:475–479. 2003.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Giampietri C, Petrungaro S, Conti S,
Facchiano A, Filippini A and Ziparo E: Cancer microenvironment and
endoplasmic reticulum stress response. Mediators Inflamm.
2015:4172812015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang M and Kaufman RJ: The impact of the
endoplasmic reticulum protein-folding environment on cancer
development. Nat Rev Cancer. 14:581–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yadav RK, Chae SW, Kim HR and Chae HJ:
Endoplasmic reticulum stress and cancer. J Cancer Prev. 19:75–88.
2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lemus L and Goder V: Regulation of
endoplasmic reticulum-associated protein degradation (ERAD) by
Ubiquitin. Cells. 3:824–847. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Bertolotti A, Zhang Y, Hendershot LM,
Harding HP and Ron D: Dynamic interaction of BiP and ER stress
transducers in the unfolded-protein response. Nat Cell Biol.
2:326–332. 2000. View
Article : Google Scholar : PubMed/NCBI
|
26
|
Fisher LW and Fedarko NS: Six genes
expressed in bones and teeth encode the current members of the
SIBLING family of proteins. Connect Tissue Res. 44(Suppl 1): 33–40.
2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Bellahcène A, Castronovo V, Ogbureke KU,
Fisher LW and Fedarko NS: Small integrin-binding ligand N-linked
glycoproteins (SIBLINGs): Multifunctional proteins in cancer. Nat
Rev Cancer. 8:212–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ogbureke KU, Nikitakis NG, Warburton G,
Ord RA, Sauk JJ, Waller JL and Fisher LW: Up-regulation of SIBLING
proteins and correlation with cognate MMP expression in oral
cancer. Oral Oncol. 43:920–932. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ogbureke KU, Abdelsayed RA, Kushner H, Li
L and Fisher LW: Two members of the SIBLING family of proteins,
DSPP and BSP, may predict the transition of oral epithelial
dysplasia to oral squamous cell carcinoma. Cancer. 116:1709–1717.
2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Anunobi CC, Koli K, Saxena G, Banjo AA and
Ogbureke KU: Expression of the SIBLINGs and their MMP partners in
human benign and malignant prostate neoplasms. Oncotarget.
7:48038–48049. 2016. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ogbureke KU, Weinberger PM, Looney SW, Li
L and Fisher LW: Expressions of matrix metalloproteinase-9 (MMP-9),
dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at
histologically negative surgical margins may predict recurrence of
oral squamous cell carcinoma. Oncotarget. 3:286–298. 2012.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Saxena G, Koli K, de la Garza J and
Ogbureke KU: Matrix metalloproteinase 20-dentin sialophosphoprotein
interaction in oral cancer. J Dent Res. 94:584–593. 2015.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Joshi R, Tawfik A, Edeh N, McCloud V,
Looney S, Lewis J, Hsu S and Ogbureke KU: Dentin
sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic
activities in human oral cancer cell line, OSC2. PLoS One. 5. pp.
e139742010, View Article : Google Scholar
|
34
|
Gkouveris I, Nikitakis NG, Aseervatham J
and Ogbureke KUE: The tumorigenic role of DSPP and its potential
regulation of the unfolded protein response and ER stress in oral
cancer cells. Int J Oncol. 53:1743–1751. 2018.PubMed/NCBI
|
35
|
Murtas D, Maric D, De Giorgi V, Reinboth
J, Worschech A, Fetsch P, Filie A, Ascierto ML, Bedognetti D, Liu
Q, et al: IRF-1 responsiveness to IFN-γ predicts different cancer
immune phenotypes. Br J Cancer. 109:76–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Ma Z, Qin H and Benveniste EN:
Transcriptional suppression of matrix metalloproteinase-9 gene
expression by IFN-gamma and IFN-beta: Critical role of STAT-1alpha.
J Immunol. 167:5150–5159. 2001. View Article : Google Scholar : PubMed/NCBI
|
37
|
Knüpfer MM, Knüpfer H, Jendrossek V, Van
Gool S, Wolff JE and Keller E: Interferon-gamma inhibits growth and
migration of A172 human glioblastoma cells. Anticancer Res.
21A:3989–3994. 2001.
|
38
|
Cheng SM, Xing B, Li JC, Cheung BK and Lau
AS: Interferon-gamma regulation of TNFalpha-induced matrix
metalloproteinase 3 expression and migration of human glioma T98G
cells. Int J Cancer. 121:1190–1196. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Chawla-Sarkar M, Lindner DJ, Liu YF,
Williams BR, Sen GC, Silverman RH and Borden EC: Apoptosis and
interferons: Role of interferon-stimulated genes as mediators of
apoptosis. Apoptosis. 8:237–249. 2003. View Article : Google Scholar : PubMed/NCBI
|
40
|
Yonekura N, Yokota S, Yonekura K, Dehari
H, Arata S, Kohama G and Fujii N: Interferon-gamma downregulates
Hsp27 expression and suppresses the negative regulation of cell
death in oral squamous cell carcinoma lines. Cell Death Differ.
10:313–322. 2003. View Article : Google Scholar : PubMed/NCBI
|
41
|
Gadkaree SK, Fu J, Sen R, Korrer MJ, Allen
C and Kim YJ: Induction of tumor regression by intratumoral STING
agonists combined with anti-programmed death-L1 blocking antibody
in a preclinical squamous cell carcinoma model. Head Neck.
39:1086–1094. 2017. View Article : Google Scholar : PubMed/NCBI
|
42
|
Xu B, Shu Y and Liu P: INF-γ sensitizes
head and neck squamous cell carcinoma cells to chemotherapy-induced
apoptosis and necroptosis through up-regulation of Egr-1. Histol
Histopathol. 29:1437–1443. 2014.PubMed/NCBI
|
43
|
Ning Y, Riggins RB, Mulla JE, Chung H,
Zwart A and Clarke R: IFNgamma restores breast cancer sensitivity
to fulvestrant by regulating STAT1, IFN regulatory factor 1,
NF-kappaB, BCL2 family members, and signaling to caspase-dependent
apoptosis. Mol Cancer Ther. 9:1274–1285. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Tan H, Zeng C, Xie J, Alghamdi NJ, Song Y,
Zhang H, Zhou A and Jin D: Effects of interferons and
double-stranded RNA on human prostate cancer cell apoptosis.
Oncotarget. 6:39184–39195. 2015. View Article : Google Scholar : PubMed/NCBI
|
45
|
Chen J, Zhao J, Chen L, Dong N, Ying Z,
Cai Z, Ji D, Zhang Y, Dong L, Li Y, et al: STAT1 modification
improves therapeutic effects of interferons on lung cancer cells. J
Transl Med. 13:2932015. View Article : Google Scholar : PubMed/NCBI
|
46
|
Liu W, Hu M, Wang Y, Sun B, Guo Y, Xu Z,
Li J and Han B: Overexpression of interleukin-18 protein reduces
viability and induces apoptosis of tongue squamous cell carcinoma
cells by activation of glycogen synthase kinase-3β signaling. Oncol
Rep. 33:1049–1056. 2015. View Article : Google Scholar : PubMed/NCBI
|
47
|
Dong D, Ni M, Li J, Xiong S, Ye W, Virrey
JJ, Mao C, Ye R, Wang M, Pen L, et al: Critical role of the stress
chaperone GRP78/BiP in tumor proliferation, survival, and tumor
angiogenesis in transgene-induced mammary tumor development. Cancer
Res. 68:498–505. 2008. View Article : Google Scholar : PubMed/NCBI
|
48
|
Fu Y, Wey S, Wang M, Ye R, Liao CP,
Roy-Burman P and Lee AS: Pten null prostate tumorigenesis and AKT
activation are blocked by targeted knockout of ER chaperone
GRP78/BiP in prostate epithelium. Proc Natl Acad Sci USA.
105:19444–19449. 2008. View Article : Google Scholar : PubMed/NCBI
|
49
|
Daneshmand S, Quek ML, Lin E, Lee C, Cote
RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, et al:
Glucose-regulated protein GRP78 is up-regulated in prostate cancer
and correlates with recurrence and survival. Hum Pathol.
38:1547–1552. 2007. View Article : Google Scholar : PubMed/NCBI
|
50
|
Cook KL, Shajahan AN, Wärri A, Jin L,
Hilakivi-Clarke LA and Clarke R: Glucose-regulated protein 78
controls cross-talk between apoptosis and autophagy to determine
antiestrogen responsiveness. Cancer Res. 72:3337–3349. 2012.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Lee E, Nichols P, Spicer D, Groshen S, Yu
MC and Lee AS: GRP78 as a novel predictor of responsiveness to
chemotherapy in breast cancer. Cancer Res. 66:7849–7853. 2006.
View Article : Google Scholar : PubMed/NCBI
|
52
|
Firczuk M, Gabrysiak M, Barankiewicz J,
Domagala A, Nowis D, Kujawa M, Jankowska-Steifer E, Wachowska M,
Glodkowska-Mrowka E, Korsak B, et al: GRP78-targeting subtilase
cytotoxin sensitizes cancer cells to photodynamic therapy. Cell
Death Dis. 4:e7412013. View Article : Google Scholar : PubMed/NCBI
|
53
|
Zhang J, Jiang Y, Jia Z, Li Q, Gong W,
Wang L, Wei D, Yao J, Fang S and Xie K: Association of elevated
GRP78 expression with increased lymph node metastasis and poor
prognosis in patients with gastric cancer. Clin Exp Metastasis.
23:401–410. 2006. View Article : Google Scholar : PubMed/NCBI
|
54
|
Son SM, Byun J, Roh SE, Kim SJ and
Mook-Jung I: Reduced IRE1α mediates apoptotic cell death by
disrupting calcium homeostasis via the InsP3 receptor. Cell Death
Dis. 5:e11882014. View Article : Google Scholar
|
55
|
Kanekura K, Ma X, Murphy JT, Zhu LJ, Diwan
A and Urano F: IRE1 prevents endoplasmic reticulum membrane
permeabilization and cell death under pathological conditions. Sci
Signal. 8:ra622015. View Article : Google Scholar : PubMed/NCBI
|
56
|
Fribley AM, Miller JR, Brownell AL,
Garshott DM, Zeng Q, Reist TE, Narula N, Cai P, Xi Y, Callaghan MU,
et al: Celastrol induces unfolded protein response-dependent cell
death in head and neck cancer. Exp Cell Res. 330:412–422. 2015.
View Article : Google Scholar
|
57
|
Liu X, Lv Z, Zou J, Liu X, Ma J, Wang J,
Sa N, Jing P and Xu W: Afatinib down-regulates MCL-1 expression
through the PERK-eIF2α-ATF4 axis and leads to apoptosis in head and
neck squamous cell carcinoma. Am J Cancer Res. 6:1708–1719.
2016.
|
58
|
Fujimoto A, Kawana K, Taguchi A, Adachi K,
Sato M, Nakamura H, Ogishima J, Yoshida M, Inoue T, Nishida H, et
al: Inhibition of endoplasmic reticulum (ER) stress sensors
sensitizes cancer stem-like cells to ER stress-mediated apoptosis.
Oncotarget. 7:51854–51864. 2016. View Article : Google Scholar : PubMed/NCBI
|
59
|
Koumenis C: ER stress, hypoxia tolerance
and tumor progression. Curr Mol Med. 6:55–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
60
|
Axten JM, Medina JR, Feng Y, Shu A,
Romeril SP, Grant SW, Li WH, Heerding DA, Minthorn E, Mencken T, et
al: Discovery of
7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H
-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a
potent and selective first-in-class inhibitor of protein kinase R
(PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem.
55:7193–7207. 2012. View Article : Google Scholar : PubMed/NCBI
|
61
|
Bobrovnikova-Marjon E, Grigoriadou C,
Pytel D, Zhang F, Ye J, Koumenis C, Cavener D and Diehl JA: PERK
promotes cancer cell proliferation and tumor growth by limiting
oxidative DNA damage. Oncogene. 29:3881–3895. 2010. View Article : Google Scholar : PubMed/NCBI
|
62
|
Vandewynckel YP, Laukens D, Geerts A,
Bogaerts E, Paridaens A, Verhelst X, Janssens S, Heindryckx F and
Van Vlierberghe H: The paradox of the unfolded protein response in
cancer. Anticancer Res. 33:4683–4694. 2013.PubMed/NCBI
|
63
|
Lin JH, Li H, Yasumura D, Cohen HR, Zhang
C, Panning B, Shokat KM, Lavail MM and Walter P: IRE1 signaling
affects cell fate during the unfolded protein response. Science.
318:944–949. 2007. View Article : Google Scholar : PubMed/NCBI
|